Target identification and assessment in the era of AI
F
Frank W. Pun
D
Dmitriy Podolskiy
E
Evgeny Izumchenko
A
Andrew Mortlock
T
Tudor I. Oprea
M
Morten Scheibye-Knudsen
K
Kristen Fortney
E
Eric Morgen
F
Feng Ren
A
Alex Zhavoronkov
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 25, Issue 7
Published
July 01, 2026
Pages
534-552
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (10)
F
Frank W. Pun
D
Dmitriy Podolskiy
E
Evgeny Izumchenko
A
Andrew Mortlock
T
Tudor I. Oprea
M
Morten Scheibye-Knudsen
K
Kristen Fortney
E
Eric Morgen
F
Feng Ren
A
Alex Zhavoronkov
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w